<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03592563</url>
  </required_header>
  <id_info>
    <org_study_id>Crec No. 2018.148</org_study_id>
    <nct_id>NCT03592563</nct_id>
  </id_info>
  <brief_title>CUHK Brain Health Longitudinal Study</brief_title>
  <acronym>BHS</acronym>
  <official_title>CUHK Brain Health Longitudinal Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to develop a large longitudinal cohort of individuals diagnosed
      with or at high risk for brain diseases (both neurological and psychiatric in nature), in
      order to identify risk factors that contribute to neurological and psychiatric diseases over
      time. The investigators seek to capture relevant information from medical records,
      electronically administered questionnaires and follow up phone-based interviews. The
      investigators expect to eventually have sufficient power from our dataset to examine risk
      factors for a variety of brain disorders, both individually and in aggregate. Our ultimate
      goal is to offer scientifically validated ways to preserve and promote brain health by
      working with our patients' needs and tracking their progress over time.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For those interested participants, our services coordinator, co-investigator or principal
      investigator will interview and explain the study in detail and obtain your consent. After
      signed the consent, the participant should complete the Neuro-QoL (Quality of Life in
      Neurological Disorders) questionnaire first, either on-site at CUHK Brain Health Centre
      located at Tsim Sha Tsui in Hong Kong, PWH or community centre. The questions in the
      questionnaire focus on the following: ability to participate in social roles, emotional and
      behavioral dyscontrol, fatigue, lower extremity function, stigma, upper extremity function,
      positive affect and well-being, satisfaction with social roles, cognitive function, anxiety
      and depression. These questions enable us to get a full picture of the participant's health.
      Participants in Green and yellow groups will receive this standard battery of questions.
      However, participants in Red group may receive an additional subset of questions based on
      their clinical diagnosis. Once again, all subjects are asked to complete this questionnaire
      for clinical evaluation purposes, regardless of whether or not they decide to participate in
      this study.

      When the participant is willing to join the study, an evaluation would be scheduled. At that
      visit, our physician and/or study coordinator will review the participant's medical history,
      current concerns, and responses to the questionnaires. Diagnostic and therapeutic
      recommendations may be offered, as warranted. The investigator or physician will determine
      whether a follow-up clinic visit is warranted. Depending on the physician's recommendations,
      the participant will either participate in a research phone call in approximately 6 months,
      or will be scheduled for in person research follow up. In addition to the phone call or
      clinic visit, and will also receive an identical questionnaire to the first one by e-mail, by
      phone, or in person. Follow-up over time will continue (either in-person or over the phone)
      using the same questionnaires at approximately 6-month intervals. During follow-up,
      participant will be screened for new signs, symptoms and diagnoses of neurological and/or
      psychiatric disorders, in order to correlate these outcomes with risk factors captured using
      the procedures described above.

      The proposed study does not involve formulating new diagnoses or directly offering treatment
      for neurological and/or psychiatric conditions. All patients admitted to PWH or other medical
      institutes will be treated according to the standard care at the corresponding institution,
      regardless of their decision to participate in this repository. Should results from this
      study lead to discovery of one or more factors associated with development of brain disease,
      the principal investigators, co-investigators, or study coordinator in the CUHK Brain Health
      Centre will inform, counsel and offer diagnostic and/or therapeutic recommendations to
      participants accordingly. The participants may be referred to relevant departments for
      follow-up clinical visits and may also be invited to participate in sister research projects
      at PWH/CUHK that have obtained ethics approval; if the participants are interested in any
      sister projects, they may be offered tests as the study procedures of these projects,
      including but not limited to blood tests, genetic tests, retinal imaging and brain imaging
      exams.

      Our study aims to follow longitudinally individuals with or at risk for neurological and
      psychiatric disease, regardless of gender or sexual orientation. The investigators focus on
      enrolling adults as the vast majority of the neurological and psychiatric conditions of
      interest are diagnosed well into adulthood; indeed, most are age-related and particularly
      frequent among individuals in the fifth decade of life and beyond. Our study uniquely
      welcomes even individuals who are healthy from a brain standpoint, and offers them an
      opportunity to increase our scientific understanding of the early transition from normal to
      pathological brain functioning. As a result, the entire population as a whole stand to
      potentially benefit from the outcomes of the proposed research.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2048</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2038</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk factors contributing to neurological and psychiatric diseases</measure>
    <time_frame>December, 2038</time_frame>
    <description>The participants' electronic medical records and questionnaires done (either symptomatic or asymptomatic) would be compared with their follow-up electronic medical records/phone follow-up interview and questionnaires done over time.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Stroke, Ischemic</condition>
  <condition>Stroke Syndrome</condition>
  <condition>Stroke</condition>
  <condition>Stroke, Acute</condition>
  <condition>Dementia</condition>
  <condition>Brain Ischemia</condition>
  <condition>Brain Diseases</condition>
  <condition>Alzheimer Disease</condition>
  <condition>Health Attitude</condition>
  <condition>Health Knowledge, Attitudes, Practice</condition>
  <condition>Health Personnel Attitude</condition>
  <condition>Healthy Aging</condition>
  <arm_group>
    <arm_group_label>Red group</arm_group_label>
    <description>Those participants who had established diagnosis of one or more neurological and/or psychiatric conditions
Baseline: The participants' medical history, signs, symptoms and diagnoses of neurological and/or psychiatric disorders would be recorded. Neuro-QoL questionnaire plus an additional subset of questions based on their clinical diagnosis should be done.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Yellow group</arm_group_label>
    <description>Those participants who are high-risk to develop one or more neurological and/or psychiatric conditions, for example:
family history (first degree relative) one or more neurological and/or psychiatric conditions;
examination, imaging or laboratory findings consistent with pre-symptomatic stages of one or more neurological and/or psychiatric disorders.
Baseline: The participants' medical history, signs, symptoms and diagnoses of neurological and/or psychiatric disorders would be recorded. Neuro-QoL questionnaire should be done.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Green group</arm_group_label>
    <description>Those participants who are not meeting criteria for Red or Yellow groups, but interested in longitudinal research on maintenance and/or improvement of their brain health.
Baseline: The participants' medical history would be recorded and Neuro-QoL questionnaire should be done.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neuro-QoL questionnaire</intervention_name>
    <description>Follow-up over time will continue (either in-person or over the phone) using the same questionnaires (depending on which group they are belongs to) at approximately 6-month intervals. During each follow-up, participants will be screened for any new signs, symptoms and diagnoses of neurological and/or psychiatric disorders, in order to correlate these outcomes with risk factors captured using the procedures described above.</description>
    <arm_group_label>Green group</arm_group_label>
    <arm_group_label>Red group</arm_group_label>
    <arm_group_label>Yellow group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      30ml of EDTA blood will be collected for genome sequencing or PCR gene expression.

      5-10ml of stool will be collected for microbiome study.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1. Chinese ONLY

          2. Hong Kong Resident
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult â‰¥ 18 years of age

          2. Fulfilling criteria for membership in one of these three groups:

               -  Red group: established diagnosis of one or more neurological and/or psychiatric
                  conditions

               -  Yellow group: high-risk to develop one or more neurological and/or psychiatric
                  conditions

                    1. family history (first degree relative) one or more neurological and/or
                       psychiatric conditions

                    2. examination, imaging or laboratory findings consistent with pre-symptomatic
                       stages of one or more neurological and/or psychiatric disorders

               -  Green group: not meeting criteria for Red or Yellow groups, but interested in
                  longitudinal research on maintenance and/or improvement of brain health

          3. Subject provides informed consent by signing and dating the written informed consent
             form

          4. Subject is willing to answer health questionnaires and be followed longitudinally

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Wai Hong LEUNG, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Neurology, The Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Wai Hong LEUNG, FRCP</last_name>
    <phone>852-35053593</phone>
    <email>drtleung@cuhk.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tiffany Chung, M.Phil</last_name>
    <phone>852-35053856</phone>
    <email>tiffanyc@cuhk.edu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Wai Hong LEUNG, FRCP</last_name>
      <phone>852-35053593</phone>
      <email>drtleung@cuhk.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Tiffany CHUNG</last_name>
      <phone>852-35053856</phone>
      <email>tiffanyc@cuhk.edu.hk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Wai Hong LEUNG, FRCP</last_name>
      <phone>852-35053593</phone>
      <email>drtleung@cuhk.edu.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 13, 2018</study_first_submitted>
  <study_first_submitted_qc>July 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>June 5, 2020</last_update_submitted>
  <last_update_submitted_qc>June 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Leung Wai Hong Thomas</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>dementia</keyword>
  <keyword>Alzheimer disease</keyword>
  <keyword>Health Brain</keyword>
  <keyword>Health knowledge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified data and health information may be sent out to our research collaborators at Massachusetts General Hospital and Harvard Medical School, where there is a sister institute for brain health for additional analysis.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>The de-identified health information and data would be stored for more than 10 years, so that we can offer scientifically validated ways to preserve and promote brain health by working with our patients' needs and tracking their progress over time. This is because individuals diagnosed with neurological and psychiatric disorders can experience the very first symptoms up to 10-20 years before diagnosis.</ipd_time_frame>
    <ipd_access_criteria>These de-identified data will be stored by collaborating institutions in a manner consistent with data storing secure procedures. Only principle investigator, study coordinator and related staffs can access.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

